The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate）and Plavix® in Healthy Participants

Clinical trial NCT07619885 · RECRUITING

Trial details

NCT number: NCT07619885
Sponsor: Shanghai CureGene Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Acute Coronary Syndromes (ACS)Recent Myocardial Infarction Recent Stroke Peripheral Arterial Disease

Start date: 2026-06-01
Primary completion: 2026-10-01
Enrollment: 136

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.